NM_002860.4:c.809-330G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002860.4(ALDH18A1):​c.809-330G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.292 in 361,078 control chromosomes in the GnomAD database, including 17,447 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 6712 hom., cov: 32)
Exomes 𝑓: 0.31 ( 10735 hom. )

Consequence

ALDH18A1
NM_002860.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.362

Publications

4 publications found
Variant links:
Genes affected
ALDH18A1 (HGNC:9722): (aldehyde dehydrogenase 18 family member A1) This gene is a member of the aldehyde dehydrogenase family and encodes a bifunctional ATP- and NADPH-dependent mitochondrial enzyme with both gamma-glutamyl kinase and gamma-glutamyl phosphate reductase activities. The encoded protein catalyzes the reduction of glutamate to delta1-pyrroline-5-carboxylate, a critical step in the de novo biosynthesis of proline, ornithine and arginine. Mutations in this gene lead to hyperammonemia, hypoornithinemia, hypocitrullinemia, hypoargininemia and hypoprolinemia and may be associated with neurodegeneration, cataracts and connective tissue diseases. Alternatively spliced transcript variants, encoding different isoforms, have been described for this gene. [provided by RefSeq, Jul 2008]
ALDH18A1 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 3
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • ALDH18A1-related de Barsy syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal recessive complex spastic paraplegia type 9B
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • P5CS deficiency
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • hereditary spastic paraplegia 9A
    Inheritance: AD, SD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • autosomal dominant complex spastic paraplegia type 9B
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 10-95628822-C-T is Benign according to our data. Variant chr10-95628822-C-T is described in ClinVar as Benign. ClinVar VariationId is 683818.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.383 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALDH18A1NM_002860.4 linkc.809-330G>A intron_variant Intron 7 of 17 ENST00000371224.7 NP_002851.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALDH18A1ENST00000371224.7 linkc.809-330G>A intron_variant Intron 7 of 17 1 NM_002860.4 ENSP00000360268.2
ALDH18A1ENST00000371221.3 linkc.803-330G>A intron_variant Intron 7 of 17 1 ENSP00000360265.3
ALDH18A1ENST00000489386.1 linkn.32G>A non_coding_transcript_exon_variant Exon 1 of 5 3

Frequencies

GnomAD3 genomes
AF:
0.274
AC:
41626
AN:
151996
Hom.:
6720
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.129
Gnomad AMI
AF:
0.365
Gnomad AMR
AF:
0.392
Gnomad ASJ
AF:
0.218
Gnomad EAS
AF:
0.0440
Gnomad SAS
AF:
0.217
Gnomad FIN
AF:
0.317
Gnomad MID
AF:
0.225
Gnomad NFE
AF:
0.353
Gnomad OTH
AF:
0.255
GnomAD4 exome
AF:
0.305
AC:
63743
AN:
208964
Hom.:
10735
Cov.:
0
AF XY:
0.294
AC XY:
33255
AN XY:
113276
show subpopulations
African (AFR)
AF:
0.131
AC:
797
AN:
6098
American (AMR)
AF:
0.424
AC:
4218
AN:
9942
Ashkenazi Jewish (ASJ)
AF:
0.227
AC:
1214
AN:
5338
East Asian (EAS)
AF:
0.0448
AC:
435
AN:
9712
South Asian (SAS)
AF:
0.225
AC:
8256
AN:
36754
European-Finnish (FIN)
AF:
0.310
AC:
2938
AN:
9476
Middle Eastern (MID)
AF:
0.252
AC:
195
AN:
774
European-Non Finnish (NFE)
AF:
0.352
AC:
42308
AN:
120118
Other (OTH)
AF:
0.315
AC:
3382
AN:
10752
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
2063
4126
6189
8252
10315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.274
AC:
41608
AN:
152114
Hom.:
6712
Cov.:
32
AF XY:
0.272
AC XY:
20224
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.129
AC:
5353
AN:
41510
American (AMR)
AF:
0.391
AC:
5975
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.218
AC:
757
AN:
3466
East Asian (EAS)
AF:
0.0435
AC:
226
AN:
5190
South Asian (SAS)
AF:
0.216
AC:
1041
AN:
4818
European-Finnish (FIN)
AF:
0.317
AC:
3346
AN:
10560
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.353
AC:
23981
AN:
67980
Other (OTH)
AF:
0.252
AC:
533
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1477
2954
4431
5908
7385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.302
Hom.:
979
Bravo
AF:
0.276
Asia WGS
AF:
0.127
AC:
445
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
3.8
DANN
Benign
0.37
PhyloP100
-0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10882644; hg19: chr10-97388579; API